HOME >> BIOLOGY >> NEWS
Steps made toward overcoming biological obstacles to cell therapy for cancer

Certain types of white blood cells assist the body in destroying cancerous tumors. Among these are CD8+ T cells. The T is for thymus, the gland near the base of the throat that both raises up and weeds out blood cells involved in immune responses.

One of the strategies being explored to eradicate established tumors is to increase the number of tumor-reactive T cells through immunization (often called a "cancer vaccine") or by growing large numbers of the patient's tumor-reactive T cells outside the body and giving them back to the patient, a method called adoptive immunotherapy.

CD8+T cells detect proteins called antigens and respond in fighting mode. If such antigens are detected on tumor cells, the CD8+ T cells punch holes in the tumor cells and destroy their contents. However, many tumor antigens are also found in normal body tissues. As a result, the thymus must get rid of most of the tumor-reactive T cells to keep the body from attacking itself.

"Those CD8+ T cells that can recognize such tumor antigens but evade thymic deletion are potentially harmful, and thus are held in check inside the body by mechanisms that make them tolerant of the protein even if it is encountered on a tumor cell," said Dr. Philip Greenberg, University of Washington (UW) professor of medicine and immunology, one of the co-authors of a Feb. 13, 2006, paper in Nature Medicine on new research in adoptive immunotherapy.

However, at times the system operates too well. Because tumor cells express higher levels of many of these antigens than do normal cells, some T cells can recognize the tumor cells and largely ignore the normal cells, but these CD8+ T cells are also held in check inside the body by mechanisms that build up their tolerance to the presence of tumor antigens. They become deficient in sending the signals that lead to tumor-cell killing.

"It is precisely these cells that might be most effective in tumor therapy, albeit with some potenti
'"/>

Contact: Leila Gray
leilag@u.washington.edu
206-685-0381
University of Washington
17-Feb-2006


Page: 1 2 3

Related biology news :

1. Bursts of waves drive immune system soldiers toward invaders
2. A decisive step toward a cure for insulin dependent diabetes
3. Cloned pigs help scientists towards a breakthrough in Alzheimers
4. Paving the way toward a vaccine against Alzheimers disease
5. Latest strategies for moving research toward a cure for diabetes explored at global scientific forum
6. Progress toward a targeted therapy for a specific form of leukemia
7. Tiny clue reveals new path toward heart disease
8. Progress toward artificial photosynthesis?
9. MIT engineer works toward clean water, more
10. Sperm proteome gives tantalizing glimpse towards the origin of sex
11. Stretching bone marrow stem cells pushes them towards becoming blood vessel

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... FREDERICK, Md. (PRWEB) , ... ... ... a leading provider of gene-to-protein and monoclonal antibody development services, today announced ... of protein-based products and services to the pharmaceutical, diagnostics, and research industries. ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of ... assays (LBA) have dominated this area. However, the use of mass spectrometry in this ... now necessitates the question “How do you choose which approach to use (LBA or ...
(Date:6/23/2020)... ... ... In its June 22 online post, business and technology news platform Superb ... founder and director of stem cell biotechnology company Asymmetrex . Superb Crew decided ... July 5 it would begin offering free tissue stem cell counting at ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... TRX ... NEON Micro-Tracer Solution, a highly accurate, contact tracing solution for identification ... workplace. Contact tracing, a core disease control measure, is a key strategy for ...
(Date:5/30/2020)... ... 2020 , ... Medrio, Inc., the leading provider of eClinical ... Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for conditions like ... in (FPI) in just seven days. The Cytovale technology will allow patients with ...
(Date:5/26/2020)... PARK, Calif. (PRWEB) , ... May 26, 2020 , ... ... , the most recognized brand of smart garage door openers, announce a new integration ... line of Wi-Fi enabled garage door openers powered by Aladdin Connect® can now be ...
(Date:5/21/2020)... ... May 20, 2020 , ... Exo ... will serve as the company’s executive vice president of product engineering and report ... disrupting the medical imaging space, bringing more than 24 years of technology leadership ...
Breaking Biology Technology:
Cached News: